The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.2 - Manufacture Of Pharmaceutical Preparations
55 jobs Number of planned job creations
Announcement Date
22 December 2016
Employment effect (start)
1 December 2016
Foreseen end date
1 January 2017
Description
Novo Nordisk is a Danish pharmaceutical company. The firm has decided to move its European headquarters from Zürich (Switzerland) to the homeland, Copenhagen (Denmark). Through the relocation 55 positions are created in Denmark. Among these, 20 employees will be relocated to Switzerland, having agreed to move to Denmark. This means that the firm hired 35 new employees. The new headquarters have been opened on 2 January 2017.
Eurofound (2016), Novo Nordisk, Reshoring in Denmark, factsheet number 144, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/144.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
